The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease

Lack of Evidence of ACE2 Expression and Replicative Infection by SARSCoV-2 in Human Endothelial Cells

(2021) Ian R. McCracken et al.   CIRCULATION

Human cardiosphere-derived stromal cells exposed to SARS-CoV-2 evolve into hyper-inflammatory/pro-fibrotic phenotype and produce infective viral particles depending on the levels of ACE2 receptor expression

(2021) Alessandra Amendola et al.   CARDIOVASCULAR RESEARCH

A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research

(2021) Suzannah J. Rihn et al.   PLOS BIOLOGY

Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model

(2021) Tingxuan Gu et al.   Frontiers in Immunology

SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2

(2021) Yuyang Lei et al.   CIRCULATION RESEARCH

SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19

(2021) Lize M. Grobbelaar et al.   BIOSCIENCE REPORTS

Spike protein of SARS‐CoV‐2 activates macrophages and contributes to induction of acute lung inflammation in male mice

(2021) Xiaoling Cao et al.   FASEB JOURNAL

Coronary microvascular dysfunction pathophysiology in COVID‐19

(2021) Jie Yin et al.   MICROCIRCULATION

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

(2020) Liang Chen et al.   CARDIOVASCULAR RESEARCH

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

(2020) Luka Nicin et al.   EUROPEAN HEART JOURNAL

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

(2020) Jun Lan et al.   NATURE

A serological assay to detect SARS-CoV-2 seroconversion in humans

(2020) Fatima Amanat et al.   NATURE MEDICINE

Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

(2020) Shutoku Matsuyama et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series

(2020) Michael G Argenziano et al.   BMJ-British Medical Journal

Myocyte Specific Upregulation of ACE2 in Cardiovascular Disease: Implications for SARS-CoV-2 Mediated Myocarditis

(2020) Nathan R. Tucker et al.   CIRCULATION

Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection

(2020) Nathalie Cardot-Leccia et al.   INTENSIVE CARE MEDICINE

Kinetics and performance of the Abbott architect SARS-CoV-2 IgG antibody assay

(2020) Fergus Hamilton et al.   JOURNAL OF INFECTION

Estimates of the severity of coronavirus disease 2019: a model-based analysis

(2020) Robert Verity et al.   LANCET INFECTIOUS DISEASES

SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects

(2020) Antoni G. Wrobel et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

(2020) Andrew D. Davidson et al.   Genome Medicine

Severe COVID-19 is a Microvascular Disease

(2020) Charles J. Lowenstein et al.   CIRCULATION

SARS-CoV-2 and the Possible Role of Raf/MEK/ERK Pathway in Viral Survival: Is This a Potential Therapeutic Strategy for COVID-19?

(2020) Morteza Ghasemnejad-Berenji et al.   PHARMACOLOGY

Neuropilin-1 is a host factor for SARS-CoV-2 infection

(2020) James L. Daly et al.   SCIENCE

Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein

(2020) Christine Toelzer et al.   SCIENCE

The S1 protein of SARS-CoV-2 crosses the blood–brain barrier in mice

(2020) Elizabeth M. Rhea et al.   NATURE NEUROSCIENCE

The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier

(2020) Tetyana P. Buzhdygan et al.   NEUROBIOLOGY OF DISEASE

Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19

(2020) Marthe Jøntvedt Jørgensen et al.   Scientific Reports

Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS‐CoV ‐2 infection

(2020) Maria A. Avanzini et al.   Stem Cells Translational Medicine

Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein

(2020) Gerard J. Nuovo et al.   Annals of Diagnostic Pathology

Human Myocardial Pericytes: Multipotent Mesodermal Precursors Exhibiting Cardiac Specificity

(2015) William C. W. Chen et al.   STEM CELLS

Function of CD147 in Atherosclerosis and Atherothrombosis

(2015) Cuiping Wang et al.   Journal of Cardiovascular Translational Research

Expansion and Characterization of Neonatal Cardiac Pericytes Provides a Novel Cellular Option for Tissue Engineering in Congenital Heart Disease

(2015) E. Avolio et al.   Journal of the American Heart Association

Isolation, bulk cultivation, and characterization of coronary microvascular pericytes: the second most frequent myocardial cell type in vitro

(2011) Stephan Nees et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Human Adult Vena Saphena Contains Perivascular Progenitor Cells Endowed With Clonogenic and Proangiogenic Potential

(2010) Paola Campagnolo et al.   CIRCULATION

CD147/EMMPRIN Acts as a Functional Entry Receptor for Measles Virus on Epithelial Cells

(2010) A. Watanabe et al.   JOURNAL OF VIROLOGY

Peptide Mimicrying Between SARS Coronavirus Spike Protein and Human Proteins Reacts with SARS Patient Serum

(2008) K.-Y. Hwa et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY